Kamola Mir recognized Femtech CEO of the Year
We’re honored to share that Lidavex Inc. has been recognized in CEO Monthly’s 2025 Awards Program, with our Founder and CEO, Kamola Mir, named Femtech CEO of the Year! This recognition reflects the collective dedication of our entire team, advisors, and partners who continue to move our mission forward — improving maternal care through innovation and compassion.
Lidavex Inc graduates from the 1st cohort of REALIZE Accelerator by ULP and wins the grand prize on the Demo Day
Lidavex Inc successfully completed the REALIZE Accelerator program by University Lab Partners. This pivotal achievement catalyzed a strategic partnership with Andrews Cooper, a renowned MedTech engineering firm. Funding awarded through the REALIZE accelerator directly supports this collaboration, furthering Lidavex Inc mission to improve maternal health.
The Rising Focus on Maternal Health: A New Era of Investment and Innovation
Maternal health is receiving unprecedented attention and investment from both public and private sectors. With initiatives led by organizations like the Bill and Melinda Gates Foundation and the Biden administration, the landscape of maternal health is poised for transformative change. This increased focus is not only addressing long-standing challenges but also paving the way for innovative solutions that promise better outcomes for mothers and their babies.
Protecting Mothers and Babies: The Risks of Vaginal Exams During PPROM
Maternal health is a critical focus in medical care, ensuring the well-being of both mothers and their babies. One area of concern is the practice of vaginal exams during preterm premature membrane rupture (PPROM). While these exams are common, they carry significant risks that can impact both the mother and the baby.